Table 1.
PBS | Adel55 | Adel55-cHSF1 | Adel55-HSF1i | Adel55-HSP70 | Adel55-HSP90 | |
---|---|---|---|---|---|---|
B16 |
0/21 |
0/19 |
20/21* |
0/21 |
12/21 |
11/21 |
CT26 | 0/22 | 0/17 | 24/25* | 0/23 | 15/23 | 14/23 |
Mice with approximately 100 mm3 B16 or CT26 tumors growing subcutaneously were treated by intratumoral administration of 5 × 108 pfu agents in the top column once a day for 2 consecutive days. Tumors were excised after 72 h and animals were re-inoculated with autologous tumor cells 2 weeks after surgery. Positive tumor formation was determined by at least minimal, palpable tumor 2 weeks from the time of tumor injection. Untreated animals as a positive control were injected and showed tumor formation. *represent statistical significance (P < 0.05, Adel55-cHSF1 vs. Adel55-HSP70 or Adel55-HSP90).